title: Anticoagulant effects of the selective factor XA inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition.
authors.affiliation: Department of Pharmacology, Merck Sharp and Dohme Research Laboratories, West Point, PA 19486.
authors.forename: C T
authors.initials: CT
authors.lastname: Dunwiddie
authors.forename: D E
authors.initials: DE
authors.lastname: Smith
authors.forename: E M
authors.initials: EM
authors.lastname: Nutt
authors.forename: G P
authors.initials: GP
authors.lastname: Vlasuk
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D060829:Arthropod Proteins; D065427:Factor Xa Inhibitors; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D007447:Invertebrate Hormones / Q000494:pharmacology*; D010314:Partial Thromboplastin Time; D010455:Peptides / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D013925:Thromboplastin / Q000037:antagonists & inhibitors*
chemical_list: D000925:Anticoagulants; D060829:Arthropod Proteins; D065427:Factor Xa Inhibitors; D036341:Intercellular Signaling Peptides and Proteins; D007447:Invertebrate Hormones; D010455:Peptides; D011994:Recombinant Proteins; C063967:tick anticoagulant peptide; C053155:antistasin; D013925:Thromboplastin